Lufeng Zheng

18PUBLICATIONS
27CO-AUTHORS
Solid tumoursEpigenetics (incl. genome methylation and epigenomics)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 02, 2026
ISGylation-mediated stabilization of CYP4Z1 fuels breast cancer initiation and progression.

|Apr 08, 2026
Spatial multiomics profiling reveals ZFP36-mediated immunometabolic reprogramming in bladder cancer.

Fangdie Ye, Xuedan Han, Weijian Li

|Feb 25, 2026
Discovery of a Novel Dual-Targeting KRASG12D/HDAC Peptide Inhibitor for the Treatment of Pancreatic Cancer.

Qiaoxuan Zhang, Yifei Geng, Haitao Chen

|Jan 22, 2026
Exploration of the mechanism of anlotinib in reversing PD-1 immunotherapy resistance: insights from single-cell sequencing.

Wanjin Shi, Yidong Zhang, Qiyi Yu

|Jan 12, 2026
Fluvastatin suppresses breast cancer initiation and progression via targeting CYP4Z1.

Huilong Li, Ying Chen, Wanjin Shi

|Sep 15, 2025
TRIM21-mediated ubiquitination of SIX2 attenuates breast cancer stemness via LGSN suppression.

Haitao Chen, Yi Zhou, Yunnan Zhang

Pageof 3

Frequent Collaborators

4 joint publications

Miaomiao Niu

2 joint publications

Xiaoman Li

2 joint publications

Hong Yao

2 joint publications

Jun Yin